Osteoarthritis Webinar

Nestlé Health Science Webinar: Current Insights and Management Options. Wednesday 7th July 2021 | 17h00 – 18h00 CEST

Lesezeit: 2 Minuten

Prof. Yves Henrotin – Osteoarthritis: Defining phenotypes, underlying inflammatory pathways and risk factors like obesity

Yves Henrotin is Professor of Pathology, Physical & Manual Therapy and Rehabilitation and director of the Musculoskeletal Innovative Research Laboratory (mSKIL) at the University of Liège (Belgium) www.mskil.uliege.be

He is also head of the Physical Therapy and Rehabilitation department at the Princess Paola Hospital, Marche-en-Famenne, Belgium. He is President of The Osteoarthritis Foundation and a member of the board of directors of the Osteoarthritis Research Society International (OARSI) between 2006 and 2013. He was coordinator of an European consortium dedicated to OA biomarkers research. He is now a principal investigator of the Belgian “Excellence of Science” (EOS) consortium named “Preservation
and repair of joint: meeting the osteoarthritis challenge”.

He has published over 260 scientific peer-reviewed papers on osteoarthritis, low back pain and sarcopenia and he is also editor or co-editor of several books. In 2005, he received a prestigious national prize (De Cooman Prize) for his contribution in the better understanding of osteoarthritis pathophysiology.

Prof. Cyrus Cooper – Osteoarthritis management: Guideline recommendations, safety aspects of oral non‑steroidal anti‑inflammatory drugs and potential alternative approaches

Cyrus Cooper is Professor of Rheumatology and Director of the MRC Lifecourse Epidemiology Unit; Vice-Dean of the Faculty of Medicine at the University of Southampton; and Professor of Musculoskeletal Science at the University of Oxford.

He is President of the International Osteoporosis Foundation; a non-executive director of University Hospital Southampton NHS Trust; a panel member of the 2021 Research Excellence Framework; an NIHR Senior Investigator; and Associate Editor of Osteoporosis International. He has previously served as Chairman of the MRC Population Health Sciences Research Network; Chairman of the Royal Osteoporosis Society of Great Britain; President of the Bone Research Society of Great Britain; and has worked on numerous Department of Health, European Union and World Health Organisation committees. He has published extensively (over 1,200 research papers; hi=211) on the causes and prevention of osteoporosis, osteoarthritis and sarcopenia; he has pioneered clinical studies on the developmental origins of osteoporosis and fracture. In 2016, he was awarded an OBE for services to medical research.

Register at www.nestlehealthsciencewebinars.com

weitere Artikel
Vorheriger ArtikelSchmerzen an der Achillessehne
Nächster ArtikelBiologische Injektate

Neueste Beiträge